|
1
|
Zhu AX, Duda DG, Sahani DV and Jain RK:
HCC and angiogenesis: Possible targets and future directions. Nat
Rev Clin Oncol. 8:292–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernandez M, Semela D, Bruix J, Colle I,
Pinzani M and Bosch J: Angiogenesis in liver disease. J Hepatol.
50:604–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Z, Dabrosin C, Xin Y, Fuster MM,
Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B,
Ribatti D, et al: Broad targeting of angiogenesis for cancer
prevention and therapy. Semin Cancer Biol. 35 (Suppl):S224–S243.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viallard C and Larrivée B: Tumor
angiogenesis and vascular normalization: Alternative therapeutic
targets. Angiogenesis. 20:409–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu
D, Yu X and Tian Y: Advanced research on vasculogenic mimicry in
cancer. J Cell Mol Med. 19:315–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Döme B, Hendrix MJ, Paku S, Tóvári J and
Tímár J: Alternative vascularization mechanisms in cancer:
Pathology and therapeutic implications. Am J Pathol. 170:1–15.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang W, Lin P, Sun BC, Cai WJ, Han CR, Li
L, Lu HH and Zhang JM: Role of vasculogenic mimicry and
endothelium-dependent vessel in metastasis of laryngeal cancer.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 47:400–405. 2012.(In
Chinese). PubMed/NCBI
|
|
9
|
Elpek GÖ: Angiogenesis and liver fibrosis.
World J Hepatol. 7:377–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Delgado-Bellido D, Serrano-Saenz S,
Fernández-Cortés M and Oliver FJ: Vasculogenic mimicry signaling
revisited: Focus on non-vascular VE-cadherin. Mol Cancer.
16:652017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ling G, Ji Q, Ye W, Ma D and Wang Y:
Epithelial-mesenchymal transition regulated by p38/MAPK signaling
pathways participates in vasculogenic mimicry formation in SHG44
cells transfected with TGF-β cDNA loaded lentivirus in vitro
and in vivo. Int J Oncol. 49:2387–2398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Lin H, Pan J, Mo C, Zhang F, Huang
B, Wang Z, Chen X, Zhuang J, Wang D and Qiu S: Vasculogenic mimicry
in prostate cancer: The roles of EphA2 and PI3K. J Cancer.
7:1114–1124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trapani F, Metcalf RL, Polanski R, Fusi A,
Hodgkinson C, Nonaka D, Hendrix MJ, Morrrow C, Blackhall F, Simpson
KL and Dive C: 264 Vasculogenic mimicries in small cell lung
cancer. European J Cancer. 50 (Suppl 6):S882014. View Article : Google Scholar
|
|
14
|
Brantley DM, Cheng N, Thompson EJ, Lin Q,
Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D,
et al: Soluble Eph A receptors inhibit tumor angiogenesis and
progression in vivo. Oncogene. 21:7011–7026. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hess AR and Hendrix MJ: Focal adhesion
kinase signaling and the aggressive melanoma phenotype. Cell Cycle.
5:478–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng N, Brantley DM, Liu H, Lin Q,
Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO and Chen
J: Blockade of EphA receptor tyrosine kinase activation inhibits
vascular endothelial cell growth factor-induced angiogenesis. Mol
Cancer Res. 1:2–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang JY, Sun T, Zhao XL, Zhang SW, Zhang
DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional
significance of VEGF-a in human ovarian carcinoma: Role in
vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Takizawa N, Crowley JL, Oh SW,
Gatto CL, Kambara T, Sato O, Li XD, Ikebe M and Luna EJ: F-actin
and myosin II binding domains in supervillin. J Biol Chem.
278:46094–46106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pestonjamasp KN, Pope RK, Wulfkuhle JD and
Luna EJ: Supervillin (p205): A novel membrane-associated, F-actin-
binding protein in the villin/gelsolin superfamily. J Cell Biol.
139:1255–1269. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oh SW, Pope RK, Smith KP, Crowley JL, Nebl
T, Lawrence JB and Luna EJ: Archvillin, a muscle-specific isoform
of supervillin, is an early expressed component of the costameric
membrane skeleton. J Cell Sci. 116:2261–2275. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Yang H, Zhang S, Wang Z, Ye F,
Liang C, Wang H and Fang Z: A novel splice variant of supervillin,
SV5, promotes carcinoma cell proliferation and cell migration.
Biochem Biophys Res Commun. 482:43–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Zhang S, Wang Z, Wang F, Cao X, Wu
Q, Zhao C, Ma H, Ye F, Wang H and Fang Z: Supervillin promotes
epithelial- mesenchymal transition and metastasis of hepatocellular
carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38
pathway. J Exp Clin Cancer Res. 37:1282018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takizawa N, Ikebe R, Ikebe M and Luna EJ:
Supervillin slows cell spreading by facilitating myosin II
activation at the cell periphery. J Cell Sci. 120:3792–3803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang Z and Luna EJ: Supervillin-mediated
suppression of p53 protein enhances cell survival. J Biol Chem.
288:7918–7929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jue C, Zhifeng W, Zhisheng Z, Lin C, Yayun
Q, Feng J, Hao G, Shintaro I, Hisamitsu T, Shiyu G and Yanqing L:
Vasculogenic mimicry in hepatocellular carcinoma contributes to
portal vein invasion. Oncotarget. 7:77987–77997. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye QH, Zhu WW, Zhang JB, Qin Y, Lu M, Lin
GL, Guo L, Zhang B, Lin ZH, Roessler S, et al: GOLM1 modulates
EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma
metastasis. Cancer Cell. 30:444–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gorrin-Rivas MJ, Arii S, Mori A, Takeda Y,
Mizumoto M, Furutani M and Imamura M: Implications of human
macrophage metalloelastase and vascular endothelial growth factor
gene expression in angiogenesis of hepatocellular carcinoma. Ann
Surg. 231:67–73. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lamouille S, Mallet C, Feige JJ and Bailly
S: Activin receptor-like kinase 1 is implicated in the maturation
phase of angiogenesis. Blood. 100:4495–4501. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu HB, Yang S, Weng HY, Chen Q, Zhao XL,
Fu WJ, Niu Q, Ping YF, Wang JM, Zhang X, et al: Autophagy-induced
KDR/VEGFR-2 activation promotes the formation of vasculogenic
mimicry by glioma stem cells. Autophagy. 13:1528–1542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Azad T, Janse van Rensburg HJ, Lightbody
ED, Neveu B, Champagne A, Ghaffari A, Kay VR, Hao Y, Shen H, Yeung
B, et al: A LATS biosensor screen identifies VEGFR as a regulator
of the Hippo pathway in angiogenesis. Nat Commun. 9:10612018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paulis YWJ, Dinnes D, Soetekouw PMMB,
Nelson PJ, Burdach S, Loewe RP, Tjan-Heijnen VCG, von Luettichau I
and Griffioen AW: Imatinib reduces the vasculogenic potential of
plastic tumor cells. Current Angiogenesis. 1:64–71. 2012.
View Article : Google Scholar
|
|
32
|
Fang Z, Takizawa N, Wilson KA, Smith TC,
Delprato A, Davidson MW, Lambright DG and Luna EJ: The
membrane-associated protein, supervillin, accelerates
F-actin-dependent rapid integrin recycling and cell motility.
Traffic. 11:782–799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu HP, Yu MC, Jiang MH, Chen JX, Yan DP,
Liu F and Ge BX: Association of supervillin with KIR2DL1 regulates
the inhibitory signaling of natural killer cells. Cell Signal.
23:487–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bai XL, Zhang Q, Ye LY, Liang F, Sun X,
Chen Y, Hu QD, Fu QH, Su W, Chen Z, et al: Myocyte enhancer factor
2C regulation of hepatocellular carcinoma via vascular endothelial
growth factor and Wnt/β-catenin signaling. Oncogene. 34:4089–4097.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren K, Zhang J, Gu X, Wu S, Shi X, Ni Y,
Chen Y, Lu J, Gao Z, Wang C and Yao N: Migration-inducing gene-7
independently predicts poor prognosis of human osteosarcoma and is
associated with vasculogenic mimicry. Exp Cell Res. 369:80–89.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang C, Xu Y, Cheng F, Hu Y, Yang S, Rao J
and Wang X: MiR-1301 inhibits hepatocellular carcinoma cell
migration, invasion, and angiogenesis by decreasing Wnt/β-catenin
signaling through targeting BCL9. Cell Death Dis. 8:e29992017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Colombo M: Liver cancer. Lancet.
3:551995.
|
|
39
|
Mashreghi M, Azarpara H, Bazaz MR, Jafari
A, Masoudifar A, Mirzaei H and Jaafari MR: Angiogenesis biomarkers
and their targeting ligands as potential targets for tumor
angiogenesis. J Cell Physiol. 233:2949–2965. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Niccoli Asabella A, Di Palo A, Altini C,
Ferrari C and Rubini G: Multimodality imaging in tumor
angiogenesis: Present status and perspectives. Int J Mol Sci.
18:E18642017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Casazza A, Fu X, Johansson I, Capparuccia
L, Andersson F, Giustacchini A, Squadrito ML, Venneri MA, Mazzone
M, Larsson E, et al: Systemic and targeted delivery of semaphorin
3A inhibits tumor angiogenesis and progression in mouse tumor
models. Arterioscler Thromb Vasc Biol. 31:741–749. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Crowley JL, Smith TC, Fang Z, Takizawa N
and Luna EJ: Supervillin reorganizes the actin cytoskeleton and
increases invadopodial efficiency. Mol Biol Cell. 20:948–962. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gimona M, Buccione R, Courtneidge SA and
Linder S: Assembly and biological role of podosomes and
invadopodia. Curr Opin Cell Biol. 20:235–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Matsumoto T, Turesson I, Book M, Gerwins P
and Claesson-Welsh L: p38 MAP kinase negatively regulates
endothelial cell survival, proliferation, and differentiation in
FGF-2-stimulated angiogenesis. J Cell Biol. 156:149–160. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kirschmann DA, Seftor EA, Hardy KM, Seftor
RE and Hendrix MJ: Molecular pathways: Vasculogenic mimicry in
tumor cells: Diagnostic and therapeutic implications. Clin Cancer
Res. 18:2726–2732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hess AR, Seftor EA, Gruman LM, Kinch MS,
Seftor RE and Hendrix MJ: VE-cadherin regulates EphA2 in aggressive
melanoma cells through a novel signaling pathway: Implications for
vasculogenic mimicry. Cancer Biol Ther. 5:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tremblay PL, Auger FA and Huot J:
Regulation of transendothelial migration of colon cancer cells by
E-selectin-mediated activation of p38 and ERK MAP kinases.
Oncogene. 25:6563–6573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nwariaku FE, Chang J, Zhu X, Liu Z, Duffy
SL, Halaihel NH, Terada L and Turnage RH: The role of p38 map
kinase in tumor necrosis factor-induced redistribution of vascular
endothelial cadherin and increased endothelial permeability. Shock.
18:82–85. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kimura T, Mogi C, Sato K, Tomura H, Ohta
H, Im DS, Kuwabara A, Kurose H, Murakami M and Okajima F:
p2y5/LPA(6) attenuates LPA(1)-mediated VE-cadherin translocation
and cell-cell dissociation through G(12/13) protein-Src-Rap1.
Cardiovasc Res. 92:149–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong
XY, Gu Q, Yao Z and Sun BC: Promotion of hepatocellular carcinoma
metastasis through matrix metalloproteinase activation by
epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med.
15:691–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shankar S, Ganapathy S, Hingorani SR and
Srivastava RK: EGCG inhibits growth, invasion, angiogenesis, and
metastasis of pancreatic cancer. Front Biosci. 13:440–452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Petty AP, Garman KL, Winn VD, Spidel CM
and Lindsey JS: Overexpression of carcinoma and embryonic
cytotrophoblast cell-specific Mig-7 induces invasion and
vessel-like structure formation. Am J Pathol. 170:1763–1780. 2007.
View Article : Google Scholar : PubMed/NCBI
|
